Houston, TX
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Cardiopulmonary Perfusion Associates Inc, founded in 1990, is a small nonprofit in the Diseases & Disorders sector that reported $469K in total revenue in fiscal year 2023. Revenue surged 27% from the prior year, signaling strong growth momentum. Expenses of $432K left a modest 8% surplus.
An affiliate of the Texas Heart Institute, Cardiopulmonary Perfusion Associates supports cardiovascular research, education, and improvements in the care of cardiovascular patients.
Cardiopulmonary Perfusion Associates, Inc. operates a school offering a post-baccalaureate perfusion technology certificate. The school trains students to use the cardiopulmonary bypass machine and...
Cardiopulmonary Perfusion Associates, Inc. operates a school offering a post-baccalaureate perfusion technology certificate. The school trains students to use the cardiopulmonary bypass machine and other equipment associated with open heart surgery. In addition, students receive extensive instruction in cardiopulmonary function and extensive experience in the operating room. The Texas Heart Institute School of Perfusion is accredited by the Commission on Accreditation of Allied Health Education Programs (CAAHEP) upon the recommendation of the Accreditation Committee for Perfusion Education (ACPE). Graduates are eligible to become a Certified Clinical Perfusionist after they take the national certification examination, which is given by the American Board of Cardiovascular Perfusion.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $468,595 | $368,619 | +0.3% |
| Expenses | $432,294 | $402,052 | +0.1% |
| Net Income | $36,301 | $-33,433 | -2.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Alfred C Glassell III | Trustee | 2.00 |
Director
|
$0 | $0 | $0 |
| David M Grimes II | Trustee | 2.00 |
Director
|
$0 | $0 | $0 |
| Eric D Wade | Trustee | 2.00 |
Director
|
$0 | $0 | $0 |
| Howard Schramm | CAO/CFO | 1.00 |
Officer
|
$0 | $23,551 | $426,136 |
| Deborah Adams | Director | 40.00 |
Officer
|
$149,215 | $12,705 | $161,920 |
| Kathleen Kibler | Research Coordinator | 40.00 |
Highest
|
$124,281 | $12,722 | $137,003 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $468,595 | $432,294 | No data | $36,301 |
| 2022 | $368,619 | $402,052 | No data | $-33,433 |
| 2021 | $417,783 | $387,376 | No data | $30,407 |
| 2020 | $376,566 | $403,838 | No data | $-27,272 |
| 2019 | $397,161 | $453,105 | No data | $-55,944 |
| 2018 | $421,525 | $409,733 | No data | $11,792 |
Compare Cardiopulmonary Perfusion Associates Inc with other nonprofits in Texas and across the country.